Normalized plasma triacylglycerols ( cf baseline ) in the TRF group were reduced by 33 mg/dL ( P = 0.032 ) and 36 mg/dL ( P = 0.072 ) after 12 and 16 weeks of intervention but no significant improvement was seen in the placebo group .